OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses
Norman, D.J.; Barry, J.M.; Bennett, W.M.; Munson, J.L.; Meyer, M.; Henell, K.; Kimball, J.; Hubert, B.
Transplantation Proceedings 23(1 Part 2): 1052-1054
1991
ISSN/ISBN: 0041-1345 PMID: 1846453 Document Number: 378028
Document emailed within 1 workday
Related Documents
Goffin, E.; Devogelaer, J.P.; Depresseux, G.; Squifflet, J.P.; Pirson, Y.; van Yperselede de Strihou, C. 2003: Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study Clinical Nephrology 59(3): 190-195Emmerling, P.; Finger, H.; Henseling, M. 1973: The effect of high doses of antigen on cyclophosphamide-induced immunosuppression Arzneimittel-Forschung 23(1): 14-17
De Castro, J.; Van de Water, A.; Wouters, L.; Xhonneux, R.; Reneman, R.; Kay, B. 1979: Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. II. Comparative study on the epileptoid activity of the narcotics used in high and massive doses in curarised and mechanically ventilated dogs Acta Anaesthesiologica Belgica 30(1): 55-69
Rasmussen, A.; Hjortrup, A.; Hansen, B.; Heslet, L.; Kirkegaard, P. 1996: Induction of immunosuppression by microemulsion cyclosporine in liver transplantation Transplantation 62(7): 1031-1033
Menkis, A.H.; McKenzie, F.N.; Thomson, D.; Jones, M.; Pflugfelder, P.; Kostuk, W.J.; Stiller, C.R. 1989: Benefits of avoidance of induction immunosuppression in heart transplantation Journal of Heart Transplantation 8(4): 311-314
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700
De Castro, J.; Van de Water, A.; Wouters, L.; Xhonneux, R.; Reneman, R.; Kay, B. 1979: Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. III. Comparative study of the acute metabolic toxicity of the narcotics used in high and massive doses in curarised and mechanically ventilated dogs Acta Anaesthesiologica Belgica 30(1): 71-90
Agha, I.A.; Rueda, J.; Alvarez, A.; Singer, G.G.; Miller, B.W.; Flavin, K.; Lowell, J.A.; Shenoy, S.; Howard, T.K.; Ramachandran, V.; Irish, W.; Schnitzle, M.A.; Brennan, D.C. 2002: Short course induction immunosuppression with thymoglobulin for renal transplant recipients Transplantation 73(3): 473-475
Bonomini, V.; Scolari, M.P.; Buscaroli, A.; Liviano D'Arcangelo, G.; Stefoni, S. 1997: Immunosuppression in renal transplantation International Journal of Artificial Organs 20(2): 73-75
Welter, H.F.; Illner, W.D.; Schleibner, S.; Abendroth, D.; Hancke, E.; Groh, J.; Land, W. 1990: Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation Transplantation Proceedings 22(5): 2272
Monaco, A.P.; Wood, M.L.; Maki, T.; Gozzo, J.J. 1989: Future strategies in immunosuppression: problems and potential for the induction of specific unresponsiveness to organ allografts in clinical transplantation Transplantation Proceedings 21(6): 3939-3942
Lemmens, H.P.; Langrehr, J.M.; Bechstein, W.O.; Blumhardt, G.; Keck, H.; Lüsebrink, R.; Knoop, M.; Lohmann, R.; Tullius, S.; Lobeck, H. 1995: Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial Transplantation Proceedings 27(1): 1140-1141
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907
Tanabe, K.; Koga, S.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Babazono, T.; Yagisawa, T.; Toma, H.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Ota, K. 1996: Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression Transplantation Proceedings 28(3): 1304-1305
Morris-Stiff, G.; Khan, A.; Quiroga, I.; Baboo, R.; Jurewicz, W.A. 1999: Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies Bmj 319(7217): 1136; Author Reply 1137
Raine, A.E.; Carter, R.; Mann, J.I.; Chapman, J.R.; Morris, P.J. 1987: Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression Transplantation Proceedings 19(1 Part 2): 1820-1821
Gupta, K.L.; Ghosh, A.K.; Kochhar, R.; Jha, V.; Chakrabarti, A.; Sakhuja, V. 1994: Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols American Journal of Gastroenterology 89(7): 1062-1065
Squifflet, J.P.; Pirson, Y.; van Cangh, P.; Otte, J.B.; van Ypersele de Strihou, C.; Alexandre, G.P. 1981: Renal transplantation in children: a comparative study between parental and well-matched cadaveric grafts Transplantation 32(4): 278-281
Schweizer, R.T.; Bow, L.; Roper, L.; Hull, D.; Bartus, S.A. 1988: Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression Clinical Transplants 1988: 147-158
Shabtai, M.; Anaise, D.; Frei, L.; Waltzer, W.C.; Frischer, Z.I.; Jao, S.; Miller, F.; Rapaport, F.T. 1989: Malakoplakia in renal transplantation: an expression of altered tissue reactivity under immunosuppression Transplantation Proceedings 21(4): 3725-3727